Chimeric Fibril-reactive Monoclonal Antibody 111F4

Known as: mAb-11-1F4, c11-1F4 mAb, Chimeric Amyloid-reactive Monoclonal Antibody 111F4 
A chimeric monoclonal antibody specifically targeting human immunoglobulin light chain (LC)-related fibrils, which may potentially be used in the… (More)

Topic mentions per year

Topic mentions per year

2003-2017
01220032017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Wall, JS, Solomon A, Kennel, SJ. Development and evaluation of agents for targeting visceral amyloid. Visceral amyloidosis is a… (More)
Is this relevant?
2010
2010
Care of patients with AL amyloidosis currently is limited by the lack of objective means to document disease extent, as well as… (More)
  • table 1
Is this relevant?
2010
2010
L iver uptake was seen in a high proportion of patients, although only 3 actually were felt to have clinically important hepatic… (More)
Is this relevant?
2007
2007
Amyloid fibrils and partially unfolded intermediates may be distinguished serologically from native amyloidogenic precursor… (More)
Is this relevant?
2007
2007
Amyloid fibrils and partially unfolded intermediates can be distinguished serologically from native amyloidogenic precursor… (More)
Is this relevant?
2006
2006
UNLABELLED Currently, there are no available means in the United States to document objectively the location and extent of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2006
Review
2006
Scintigraphic imaging of radioiodinated serum amyloid P-component is a proven method for the clinical detection of peripheral… (More)
Is this relevant?
2003
2003
PURPOSE We had previously reported that certain of our murine (m) antihuman light chain monoclonal antibodies (mAbs) recognized… (More)
Is this relevant?
Review
2003
Review
2003
Heretofore, treatment of patients with primary or light chain-associated (AL) amyloidosis has been directed toward reducing the… (More)
Is this relevant?